Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 4, 2005, Pages 536-546

  Lin, Ya Wen ^a   Lee, Hsuan Shu ^b   Chen, Chien Hung ^b   Huang, Guan Tarn ^b   Lee, Po Huang ^b   Sheu, Jin Chuan ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Clonality; Hepatocellular carcinoma; Laser capture microdissection; Loss of heterozygosity

Indexed keywords

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME ANALYSIS; CLONAL VARIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MAPPING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 19944376138     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03609.x     Document Type: Article

References (51)

1. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
2. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 71-80.
3. Chen DS, Kuo GC, Sung JL et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J. Infect. Dis. 1990; 162: 817-22.
4. Sheu JC, Huang GT, Shih LN et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992; 103: 1322-7.
5. Sheu JC, Huang GT, Lee PH et al. Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res. 1992; 52: 6098-100.
6. Chen DS, Sheu JC, Sung JL et al. Small hepatocellular carcinoma - a clinicopathological study in thirteen patients. Gastroenterology 1982; 83: 1109-19.
7. Sheu JC, Sung JL, Chen DS et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer 1985; 56: 660-66.
8. Sheu JC, Chen DS, Sung JL et al. Hepatocellular carcinoma: US evolution in the early stage. Radiology 1985; 155: 463-7.
9. Makuuchi M, Hasegawa H, Yamazaki S. Intraoperative ultrasonic examination for hepatectomy. Ultrasound Med. Biol. 1983; (Suppl. 2): 493-7.
10. Sheu JC, Lee CS, Sung JL, Chen DS, Yang PM, Lin TY. Intraoperative hepatic ultrasonography - an indispensable procedure in resection of small hepatocellular carcinomas. Surgery 1985; 97: 97-103.
11. Sheu JC, Huang GT, Chen DS et al. Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems. Radiology 1987; 163: 43-8.
12. Shinagawa T, Ohto M, Kimura K et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984; 86: 495-502.
13. Lee CS, Sung JL, Hwang LY et al. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery 1986; 99: 481-90.
14. Hsu HC, Wu TT, Wu MZ, Sheu JC, Lee CS, Chen DS. Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications. Cancer 1988; 61: 2095-9.
15. Chen YJ, Yeh SH, Chen JT et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000; 119: 31-40.
16. Sheu JC, Huang GT, Chou HC et al. Multiple hepatocellular carcinomas at the early stage have different clonality. Gastroenterology 1993; 105: 1471-6.
17. Okusaka T, Okada S, Nose H et al. The prognosis of patients with hepatocellular carcinoma of multicentric origin. Hepatogastroenterology 1996; 43: 919-25.
18. Kawai S, Imazeki F, Yokosuka O et al. Clonality in hepatocellular carcinoma: analysis of methylation pattern of polymorphic X-chromosome-linked phosphoglycerate kinase gene in females. Hepatology 1995; 22: 112-17.
19. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995; 10: 1725-9.
20. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 1995; 11: 447-9.
21. Ding SF, Habib NA, Dooley J, Wood C, Bowles L, Delhanty JD. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br. J. Cancer 1991; 64: 1083-7.
22. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994; 54: 281-5.
23. Fujiwara Y, Ohata H, Kuroki T et al. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene 1995; 10: 891-5.
24. Lin YW, Lu FJ, Liu LY et al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur. J. Cancer 1999; 35: 1730-34.
25. Lin YW, Sheu JC, Huang GT et al. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. Eur. J. Cancer 1999; 35: 652-8.
26. Nose H, Imazeki F, Ohio M, Omata M. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 1993; 72: 355-60.
27. Sheu JC, Lin YW, Chou HC et al. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Br. J. Cancer 1999; 80: 468-76.
28. Wang HP & Rogler CE. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet. 1988; 48: 72-8.
29. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994; 54: 4188-92.
30. Yeh SH, Chen PJ, Lai MY, Chen DS. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology 1996; 110: 184-92.
31. Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ et al. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994; 9: 101-7.
32. Lin YW, Lee IN, Chen CH et al. Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-beta-HSD gene localized to the region. Int. J. Cancer 2001; 93: 74-9.
33. Chen T, Sahin A, Aldaz CM. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res. 1996; 56: 5605-9.
34. Driouch K, Dorion-Bonnet F, Briffod M, Champeme MH, Longy M, Lidereau R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer 1997; 19: 185-91.
35. Elo JP, Harkonen P, Kyllonen AP et al. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res. 1997; 57: 3356-9.
36. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Vihko P. Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient. Br. J. Cancer 1999; 79: 156-60.
37. Li C, Berx G, Larsson C et al. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes Cancer 1999; 24: 175-82.
38. Suzuki H, Komiya A, Emi M et al. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 1996; 17: 225-33.
39. Yeh SH, Chen PJ, Shau WY et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001; 121: 699-709.
40. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science 1996; 274: 998-1001.
41. Weissenbach J, Gyapay G, Dib C et al. A second-generation linkage map of the human genome. Nature 1992; 359: 794-801.
42. Kawai S, Imazeki F, Yokosuka O et al. Clonality in hepatocellular carcinoma: analysis of methylation pattern of polymorphic X-chromosome-linked phosphoglycerate kinase gene in females. Hepatology 1995; 22: 112-17.
43. Clayton RN, Pfeifer M, Atkinson AB et al. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. Clin. Cancer Res. 2000; 6: 3973-82.
44. Morimoto O, Nagano H, Sakon M et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J. Hepatol. 2003; 39: 215-21.
45. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn. Mol. Pathol. 2001; 10: 24-33.
46. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997; 14: 2927-33.
47. Slagle BL, Zhou YZ, Birchmeier W, Scorsone KA. Deletion of E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 1993; 18: 757-62.
48. Tsuda H, Zhang WD, Shimosato Y et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1990; 87: 6791-4.
49. Buetow KH, Murray JC, Israel JL et al. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1989; 86: 8852-6.
50. Yeung RS, Bell DW, Testa JR et al. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Onogene 1993; 8: 3465-8.
51. Kamatani N. Adenine phosphoribosyltransferase (APRT). Nippon Rinsho 1996; 54: 3213-19.